跳至主要内容
临床试验/EUCTR2012-001589-13-GB
EUCTR2012-001589-13-GB进行中(未招募)不适用

The effect of Aspirin on REducing iNflammation in human in vivo model of Acute lung injury (ARENA) - Aspirin in a model of acute lung injury in healthy volunteers

Belfast Health and Social Care Trust0 个研究点开始时间: 2012年5月18日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Healthy non-smoking subjects
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • 1.Age < 18 years
  • 2.Pregnancy or breast feeding or woman of childbearing potential not using adequate contraception.
  • 3.Participation in a clinical trial of an investigational medicinal product within 30 days
  • 4.Consent declined
  • 5.Aspirin or non steroidal anti-inflammatory (NSAID) use in the past 4 weeks
  • 6.History of asthma
  • 7.Known aspirin or NSAID hypersensitivity
  • 8.History of peptic ulcer disease
  • 9.Platelet count < 150 x 106/ml
  • 10.Aspirin resistance
  • Aspirin resistance is uncommon and therefore it is not anticipated that it will have a significant impact on the study. However subjects who do not show a change in measures of aspirin responsiveness following aspirin will be excluded. Aspirin responsiveness will be measured by Optical Platelet Aggregometry

研究者

相似试验